Targeted proteomics for metabolic pathway optimization: Application to terpene production

被引:147
作者
Redding-Johanson, Alyssa M. [1 ]
Batth, Tanveer S. [1 ]
Chan, Rossana [1 ]
Krupa, Rachel [1 ]
Szmidt, Heather L. [1 ]
Adams, Paul D. [1 ]
Keasling, Jay D. [1 ]
Lee, Taek Soon [1 ]
Mukhopadhyay, Aindrila [1 ]
Petzold, Christopher J. [1 ]
机构
[1] Lawrence Berkeley Natl Lab, Phys Biosci Div, Joint BioEnergy Inst, Emeryville, CA 94608 USA
关键词
Targeted proteomics; Selected-Reaction Monitoring (SRM); Mevalonate pathway; Amorphadiene production; Metabolic pathway optimization; E; coli; ESCHERICHIA-COLI; PROTEIN EXPRESSION; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; MEVALONATE PATHWAY; MASS-SPECTROMETRY; PLASMID; QUANTIFICATION; REPLICATION; STRATEGIES;
D O I
10.1016/j.ymben.2010.12.005
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Successful metabolic engineering relies on methodologies that aid assembly and optimization of novel pathways in microbes. Many different factors may contribute to pathway performance, and problems due to mRNA abundance, protein abundance, or enzymatic activity may not be evident by monitoring product titers. To this end, synthetic biologists and metabolic engineers utilize a variety of analytical methods to identify the parts of the pathway that limit production. In this study, targeted proteomics, via selected-reaction monitoring (SRM) mass spectrometry, was used to measure protein levels in Escherichia coli strains engineered to produce these squiterpene, amorpha-4,11-diene. From this analysis, two mevalonate pathway proteins, mevalonate kinase (MK) and phosphomevalonate kinase (PMK) from Saccharomyces cerevisiae, were identified as potential bottlenecks. Codon-optimization of the genes encoding MK and PMK and expression from a stronger promoterled to significantly improved MK and PMK protein levels and over three-fold improved final amorpha-4,11-diene titer(> 500 mg/L). (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:194 / 203
页数:10
相关论文
共 55 条
[1]   Tuning genetic control through promoter engineering [J].
Alper, H ;
Fischer, C ;
Nevoigt, E ;
Stephanopoulos, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (36) :12678-12683
[2]   BglBricks: A flexible standard for biological part assembly [J].
Anderson J.C. ;
Dueber J.E. ;
Leguia M. ;
Wu G.C. ;
Arkin A.P. ;
Keasling J.D. .
Journal of Biological Engineering, 4 (1)
[3]   Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins [J].
Anderson, L ;
Hunter, CL .
MOLECULAR & CELLULAR PROTEOMICS, 2006, 5 (04) :573-588
[4]   Optimization of the mevalonate-based isoprenoid biosynthetic pathway in Escherichia coli for production of the anti-malarial drug precursor amorpha-4,11-diene [J].
Anthony, Jennifer R. ;
Anthony, Larry C. ;
Nowroozi, Farnaz ;
Kwon, Gina ;
Newman, Jack D. ;
Keasling, Jay D. .
METABOLIC ENGINEERING, 2009, 11 (01) :13-19
[5]   Selective detection of membrane proteins without antibodies - A mass spectrometric version of the Western blot [J].
Arnott, D ;
Kishiyama, A ;
Luis, EA ;
Ludlum, SG ;
Marsters, JC ;
Stults, JT .
MOLECULAR & CELLULAR PROTEOMICS, 2002, 1 (02) :148-156
[6]   Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolism [J].
Baillie, Thomas A. .
CHEMICAL RESEARCH IN TOXICOLOGY, 2008, 21 (01) :129-137
[7]   Evolving strategies for enzyme engineering [J].
Bloom, JD ;
Meyer, MM ;
Meinhold, P ;
Otey, CR ;
MacMillan, D ;
Arnold, FH .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 2005, 15 (04) :447-452
[8]  
CARPOUSIS A, 2009, PROGR MOL BIOL TRANS
[9]   Debottlenecking the 1,3-propanediol pathway by metabolic engineering [J].
Celinska, E. .
BIOTECHNOLOGY ADVANCES, 2010, 28 (04) :519-530
[10]   Genetic alterations for increased coumarin production lead to metabolic changes in the medicinally important Pelargonium sidoides DC (Geraniaceae) [J].
Colling, J. ;
Groenewald, J-H. ;
Makunga, N. P. .
METABOLIC ENGINEERING, 2010, 12 (06) :561-572